Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessions.
The current introduction summarizes the five scientific sessions (bone marrow microenvironment and animal models of bone metastasis; prostate carcinoma; multiple myeloma; breast carcinoma; and preclinical and clinical studies on metastasis: future directions) and provides an overview of the proceedings of the Third North American Symposium on Skeletal Complications of Malignancy, Bethesda, Maryland, April 25-27, 2002.
Mohla
Suresh
S
Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20892, USA. sm82e@nih.gov
Weilbacher
Katherine N
KN
Cher
Michael L
ML
Oyajobi
Babatunde O
BO
Poznak
Catherine Van
CV
Clohisy
Dennis R
DR
D000818:Animals; D001853:Bone Marrow / Q000503:physiopathology*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000473:pathology*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D004164:Diphosphonates; D013792:Thalidomide